What Align Technology's latest 10-Q says: 4 signals

Align Technology filed its latest 10-Q with the SEC on Aug 5, 2026. It discusses AI investment, compliance burden and governance change.

Public (ALGN)Medical Equipment Manufacturing10,000+ employeesaligntech.comLinkedIn

Filed: Aug 5, 2026
Filings: 2
Signals: 15

10-Q · latest 10

What Align Technology's 10-Q filings say

10-Q
Filed Aug 5, 2026 · 4 signals
SEC EDGAR
- Governance changeNegative
  Company confirms it is currently subject to shareholder activism, creating pressure for change.
  Responding to activist shareholders is described as costly and disruptive, diverting management attention.
- AI investmentNegative
  Align flags AI-related IP risks amid costly litigation with competitors Straumann and Angelalign
  Align is using AI but fears it could lead to IP infringement or loss, a critical concern given its ongoing, expensive IP lawsuits against competitors which cost $38.7M in the quarter.
  $38.7M
  Legal settlements and contingencies expense for the three months ended June 30, 2026
  AIartificial intelligenceStraumannAngelalign Technology Inc.
- Compliance burdenNegative
  Facing complex new global tax laws, including OECD's Pillar Two 15% minimum tax.
  The company is navigating complex and evolving tax regulations like BEPS and the OECD's Pillar Two, alongside indirect taxes (VAT, GST).
  15%
  OECD/G20 Framework’s Pillar Two global minimum tax rate
- Product liabilityNegative
  Cites risks of using AI in product development, including IP infringement and inaccurate outputs.
  The company is concerned that using AI for product development could lead to IP violations, flawed product outputs, and reputational harm.
  AI
10-Q
Filed May 6, 2026 · 11 signals
SEC EDGAR
- Governance changeNegative
  Currently subject to shareholder activism, creating pressure for strategic changes
  The company confirms it is a target of shareholder activism, which can disrupt business, divert management's attention, and force changes in strategy, operations, or governance.
- Litigation materialNegative
  Engaged in ongoing IP litigation with competitors Straumann and Angelalign Technology
  Align is involved in extensive and costly intellectual property litigation with key competitors, including Straumann and Angelalign.
  StraumannAngelalign Technology Inc.
- Compliance burdenNeutral
  Investing in AI while acknowledging risks of inaccurate, biased, or flawed outputs
  Align is actively investing in AI for products and operations but is concerned about unintended consequences like inaccurate outputs, bias, and IP infringement.
  AImachine learning
- AI investmentPositive
  Making significant investments in the development and deployment of AI and machine learning.
  Align confirms it is making 'significant investments' in AI and machine learning for its products and operations.
  AIMLmachine learning
- RestructuringNegative
  Company confirms it is currently subject to shareholder activism.
  Align explicitly states it is 'currently subject to shareholder activism,' which creates significant pressure on management to improve performance and can lead to strategic reviews, cost-cutting, or organizational changes.
- Market share lossNegative
  Facing risk of market share loss from counterfeit products and IP infringement
  The company explicitly states that failures in protecting its extensive IP portfolio could allow competitors to create copycat or counterfeit products.

Showing 10 of 15 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Align Technology earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call date	Period	What the company said
Oct 29, 2025	Q3 FY2025	Committing $100M in capital expenditures for technology upgrades in FY2025.The company has allocated a significant budget of approximately $100 million for capital expenditures in fiscal 2025, with a specific focus on technology upgrades. This presents a prime opportunity for vendors in the tech space to engage with a company that has a confirmed, large budget for modernization.
Oct 29, 2025	Q3 FY2025	Launching AI-powered software to automate and accelerate treatment planning.Align is heavily investing in AI and machine learning to power its next-generation treatment planning software, ClinCheck Live Plan. This focus on AI-driven automation and efficiency creates opportunities for vendors specializing in AI/ML infrastructure, development tools, and data platforms.
Oct 29, 2025	Q3 FY2025	Announced a series of new digital product innovations and software capabilities.The company is launching a suite of new digital solutions, including AI-enabled X-ray assessment and patient engagement tools, to enhance its digital workflow. This wave of product innovation indicates spending on R&D, software development, and go-to-market infrastructure, creating needs for supporting technology and service vendors.
Oct 29, 2025	Q3 FY2025	Expects strong sequential revenue growth in Q4, with revenues up to $1.045B.The company issued positive Q4 guidance, projecting sequential revenue growth, which indicates strong business momentum and financial health heading into year-end. This financial strength supports continued investment in strategic initiatives and technology.
Oct 29, 2025	Q3 FY2025	Targeting 100+ bps operating margin improvement in FY2026 via efficiency initiatives.Align has a strategic goal to improve operating margins by at least 100 basis points next fiscal year through restructuring and other initiatives focused on efficiency. This commitment to cost reduction and enhanced capital efficiency often requires investment in automation, process optimization, and other technologies that drive operational leverage.
Oct 29, 2025	Q3 FY2025	Expanding new product pilots into more European countries in 2026.The company is actively expanding its geographic footprint, with plans to roll out its exocad ART software to more countries in Europe next year. This expansion signals growth and creates potential needs for localized technology infrastructure, marketing tech, and operational support systems for new markets.

Signal API · MCP

Track Align Technology with the Signal API

One POST /v1/companies/enrich call with aligntech.com returns Align Technology 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"aligntech.com","signal_types":["sec-10q"],"limit":20}'

Same industry

Questions about Align Technology 10-Q

When did Align Technology file its latest 10-Q?

Align Technology filed its latest 10-Q on Aug 5, 2026. The one before it was filed on May 6, 2026.

What did Align Technology disclose in its latest 10-Q?

From the filing dated Aug 5, 2026: Company confirms it is currently subject to shareholder activism, creating pressure for change.

What did Align Technology say on its recent earnings calls?

Q3 FY2025: Committing $100M in capital expenditures for technology upgrades in FY2025. (dated Oct 29, 2025).

Where can I read Align Technology's 10-Q filing?

The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1097149/000109714926000060/algn-20260630.htm. This page summarizes what the filing says and links to it.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of Sep 30, 2026.

How this data is built →Get it from the Signal API →

What Align Technology's latest 10-Q says: 4 signals

What Align Technology's 10-Q filings say

Align Technology earnings headlines

Track Align Technology with the Signal API

10-Q at related companies

Questions about Align Technology 10-Q